{"id":"https://openalex.org/W3107051820","doi":"https://doi.org/10.5414/cp203814","title":"Occurrence of metabolic diseases associated with antipsychotic use among Korean patients with schizophrenia","display_name":"Occurrence of metabolic diseases associated with antipsychotic use among Korean patients with schizophrenia","publication_year":2020,"publication_date":"2020-11-30","ids":{"openalex":"https://openalex.org/W3107051820","doi":"https://doi.org/10.5414/cp203814","mag":"3107051820","pmid":"https://pubmed.ncbi.nlm.nih.gov/33250073"},"language":"en","primary_location":{"id":"doi:10.5414/cp203814","doi":"https://doi.org/10.5414/cp203814","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp203814","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072181811","display_name":"Sunghee Kuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunghee Kuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100615887","display_name":"Seoyoung C. Kim","orcid":"https://orcid.org/0000-0002-2517-3579","observed_orcids":["https://orcid.org/0000-0002-2517-3579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seoyoung Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020102478","display_name":"Euitae Kim","orcid":"https://orcid.org/0000-0003-0914-2331","observed_orcids":["https://orcid.org/0000-0003-0914-2331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Euitae Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030905874","display_name":"Bo\u2010Hyung Kim","orcid":"https://orcid.org/0000-0003-3233-2918","observed_orcids":["https://orcid.org/0000-0003-3233-2918"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bo-Hyung Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030458503","display_name":"Woojoo Lee","orcid":"https://orcid.org/0000-0001-7447-7045","observed_orcids":["https://orcid.org/0000-0001-7447-7045"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Woojoo Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101741767","display_name":"Sang\u2010In Park","orcid":"https://orcid.org/0000-0002-8302-2488","observed_orcids":["https://orcid.org/0000-0002-8302-2488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sang-In Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18662245,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"59","issue":"04","first_page":"298","last_page":"307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/antipsychotic-induced-metabolic-side-effects","display_name":"antipsychotic-induced metabolic side effects","score":0.7229999899864197},{"id":"https://openalex.org/keywords/metabolic-disorders","display_name":"metabolic disorders","score":0.9449999928474426},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.8740000128746033},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":1.0},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9459999799728394},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.9909999966621399},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7089999914169312},{"id":"https://openalex.org/keywords/korean-patients","display_name":"Korean patients","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7930898070335388},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7531100511550903},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5993316769599915},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.4976702034473419},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4935528039932251},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3475217819213867}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008659","descriptor_name":"Metabolic Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056910","descriptor_name":"Republic of Korea","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cp203814","doi":"https://doi.org/10.5414/cp203814","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp203814","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:33250073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33250073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6905129878","https://openalex.org/W1998874477","https://openalex.org/W2979075316","https://openalex.org/W6940791879","https://openalex.org/W4410265531","https://openalex.org/W4301183514","https://openalex.org/W4296628468","https://openalex.org/W2117590927","https://openalex.org/W2621233730","https://openalex.org/W2252986970"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Metabolic":[1],"side":[2],"effects":[3],"of":[4,20,40,47,89,101,115,138,150,173,189,199,203,220,237],"antipsychotics":[5,120,208],"significantly":[6],"affect":[7],"adherence":[8],"to":[9,13,50,85,177,253],"medication.":[10],"We":[11,36],"aimed":[12],"identify":[14],"factors":[15],"associated":[16,92,134,233],"with":[17,26,64,93,135,234,242,247],"the":[18,30,38,60,78,83,87,99,146,183,201,235],"occurrence":[19,88,236],"metabolic":[21,75,90,102,139,174,238],"diseases":[22,76,91,103,140,175,239],"among":[23],"Korean":[24],"patients":[25,62,71,184,204,241],"schizophrenia":[27],"(SCZ)":[28],"from":[29],"national":[31],"health":[32],"insurance":[33],"system":[34],"database.":[35],"evaluated":[37,108],"frequency":[39],"antidiabetic":[41,190],"and":[42,68,104,118,160,223,226,228],"antihyperlipidemic":[43,192],"use":[44,149,219],"after":[45,197],"diagnosis":[46,79,198],"SCZ":[48,65],"according":[49],"typical":[51,117,215,222],"or":[52,191],"atypical":[53,119,147,207,224],"antipsychotic":[54,94],"use.":[55,95,144,181],"MATERIALS":[56],"AND":[57],"METHODS:":[58],"Among":[59,145,182],"43,800":[61],"diagnosed":[63],"between":[66,98],"2008":[67],"2012,":[69],"29,591":[70],"who":[72],"had":[73],"no":[74],"before":[77],"were":[80,107],"included":[81],"in":[82,240],"analysis":[84],"investigate":[86],"The":[96,218],"associations":[97],"development":[100],"patient":[105],"characteristics":[106],"using":[109,185,205,213],"logistic":[110],"regression":[111],"analysis.":[112],"RESULTS:":[113],"Use":[114],"both":[116,221],"(multivariate-adjusted":[121,152,162],"odds":[122],"ratio":[123],"(OR),":[124],"1.2513;":[125],"95%":[126,155,165],"confidence":[127],"interval":[128],"(CI),":[129],"1.0953":[130],"-":[131,158,168],"1.4294)":[132],"was":[133,209],"higher":[136,171],"incidence":[137,172],"than":[141,211],"without":[142,179],"their":[143,180],"antipsychotics,":[148,225],"clozapine":[151,227],"OR,":[153,163],"1.1959;":[154],"CI,":[156,166],"1.0086":[157],"1.4179)":[159],"quetiapine":[161,229],"1.1284;":[164],"1.0446":[167],"1.2189)":[169],"showed":[170],"compared":[176],"that":[178],"\u2265":[186],"1":[187],"type":[188],"agents":[193],"within":[194],"6":[195],"years":[196],"SCZ,":[200],"proportion":[202],"only":[206,214],"greater":[210],"those":[212],"antipsychotics.":[216],"CONCLUSION:":[217],"treatment,":[230],"may":[231],"be":[232],"SCZ.":[243],"Additional":[244],"prospective":[245],"studies":[246],"accurate":[248],"dosage":[249],"information":[250],"are":[251],"needed":[252],"validate":[254],"our":[255],"findings.":[256]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-12-07T00:00:00"}